PL2424530T3 - Sposób i kompozycja do leczenia cukrzycowej kwasicy ketonowej - Google Patents
Sposób i kompozycja do leczenia cukrzycowej kwasicy ketonowejInfo
- Publication number
- PL2424530T3 PL2424530T3 PL10770393T PL10770393T PL2424530T3 PL 2424530 T3 PL2424530 T3 PL 2424530T3 PL 10770393 T PL10770393 T PL 10770393T PL 10770393 T PL10770393 T PL 10770393T PL 2424530 T3 PL2424530 T3 PL 2424530T3
- Authority
- PL
- Poland
- Prior art keywords
- composition
- treating diabetic
- diabetic ketoacidosis
- ketoacidosis
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17428309P | 2009-04-30 | 2009-04-30 | |
| EP10770393.6A EP2424530B1 (en) | 2009-04-30 | 2010-04-30 | Method and composition for treating diabetic ketoacidosis |
| PCT/US2010/033083 WO2010127197A2 (en) | 2009-04-30 | 2010-04-30 | Method and composition for treating diabetic ketoacidosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2424530T3 true PL2424530T3 (pl) | 2016-07-29 |
Family
ID=43032791
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10770393T PL2424530T3 (pl) | 2009-04-30 | 2010-04-30 | Sposób i kompozycja do leczenia cukrzycowej kwasicy ketonowej |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8980874B2 (pl) |
| EP (1) | EP2424530B1 (pl) |
| JP (1) | JP5536198B2 (pl) |
| CN (1) | CN102548553B (pl) |
| AU (1) | AU2010242930B2 (pl) |
| BR (1) | BRPI1013904A2 (pl) |
| CA (1) | CA2759795C (pl) |
| ES (1) | ES2562957T3 (pl) |
| PL (1) | PL2424530T3 (pl) |
| WO (1) | WO2010127197A2 (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5498571B2 (ja) | 2009-04-30 | 2014-05-21 | ミッドウェスタン ユニバーシティ | センタキンを用いた新規の治療方法 |
| BR112020021466A2 (pt) * | 2018-04-20 | 2021-01-19 | Virginia Tech Intellectual Properties, Inc. | Oxadiazolopirazinas e oxadiazolopiridinas úteis como desacopladores mitocondriais |
| EP4094759A1 (en) * | 2019-10-30 | 2022-11-30 | Perfuse Therapeutics, Inc. | Treatment of ocular diseases using endothelin receptor antagonists |
| CA3168810A1 (en) | 2020-02-06 | 2021-08-12 | Perfuse Therapeutics, Inc. | Compositions for treatment of ocular diseases |
| IL296291A (en) * | 2020-03-11 | 2022-11-01 | Amorphical Ltd | Amorphous calcium carbonate to treat acidosis |
| IL307997A (en) | 2021-04-30 | 2023-12-01 | Perfuse Therapeutics Inc | Pharmaceutical preparations and intravitreal drug delivery systems for the treatment of eye diseases |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5922681A (en) * | 1992-09-14 | 1999-07-13 | Warner-Lambert Company | Endothelin antagonists |
| US20070293429A1 (en) * | 2004-10-08 | 2007-12-20 | Therapei Pharmaceuticals, Inc. | Vasoactive Intestinal Polypeptide Compositions |
| WO2008043102A2 (en) * | 2006-10-06 | 2008-04-10 | Transition Therapeutics Inc. | Vasoactive intestinal polypeptide compositions |
| CA2904447C (en) * | 2007-08-22 | 2017-01-03 | Abbvie Deutschland Gmbh & Co Kg | Therapy for complications of diabetes |
-
2010
- 2010-04-30 ES ES10770393.6T patent/ES2562957T3/es active Active
- 2010-04-30 PL PL10770393T patent/PL2424530T3/pl unknown
- 2010-04-30 BR BRPI1013904A patent/BRPI1013904A2/pt not_active Application Discontinuation
- 2010-04-30 CN CN201080030271.1A patent/CN102548553B/zh active Active
- 2010-04-30 WO PCT/US2010/033083 patent/WO2010127197A2/en active Application Filing
- 2010-04-30 JP JP2012508762A patent/JP5536198B2/ja active Active
- 2010-04-30 CA CA2759795A patent/CA2759795C/en active Active
- 2010-04-30 EP EP10770393.6A patent/EP2424530B1/en active Active
- 2010-04-30 AU AU2010242930A patent/AU2010242930B2/en active Active
- 2010-04-30 US US13/266,314 patent/US8980874B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN102548553B (zh) | 2016-07-13 |
| US20120070513A1 (en) | 2012-03-22 |
| JP5536198B2 (ja) | 2014-07-02 |
| CA2759795A1 (en) | 2010-11-04 |
| CA2759795C (en) | 2016-11-29 |
| AU2010242930B2 (en) | 2015-10-08 |
| EP2424530A2 (en) | 2012-03-07 |
| WO2010127197A3 (en) | 2011-03-31 |
| AU2010242930A1 (en) | 2011-11-17 |
| ES2562957T3 (es) | 2016-03-09 |
| US8980874B2 (en) | 2015-03-17 |
| WO2010127197A2 (en) | 2010-11-04 |
| BRPI1013904A2 (pt) | 2016-07-19 |
| EP2424530A4 (en) | 2012-09-12 |
| EP2424530B1 (en) | 2015-12-16 |
| CN102548553A (zh) | 2012-07-04 |
| JP2012525436A (ja) | 2012-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2396019A4 (en) | METHOD AND COMPOSITIONS FOR SKIN TREATMENT | |
| ZA201101055B (en) | Compositions and methods for treating osteoarthritis | |
| EP2376077A4 (en) | COMPOSITION AND METHOD FOR THE TREATMENT OF DIABETES | |
| IL210097A0 (en) | Compositions and methods for treating unfluenza | |
| EP2504428A4 (en) | METHOD AND COMPOSITIONS FOR TREATING OXALATE-MEDIATED SUFFERING | |
| ZA201006293B (en) | Composition and method for seed treatment use | |
| EP2413947A4 (en) | METHOD AND COMPOSITION FOR TREATING HYGIENE ASSOCIATED WITH HYPER-HYPER-REACTIVITY | |
| EP2429584A4 (en) | TREATMENT PROCEDURE AND COMPOSITIONS | |
| ZA201303222B (en) | Composition and method for treating skin conditions | |
| EP2415362A4 (en) | CIGARETTE AND METHOD FOR PROCESSING A CIGARETTE MATERIAL | |
| GB0912468D0 (en) | Composition and method | |
| EP2480246A4 (en) | COMPOSITION AND METHOD FOR THE TREATMENT OF DIABETES | |
| IL216146A0 (en) | Methods and compositions for treating lupus | |
| HK1171379A1 (en) | Composition for improving brain function and method for improving brain function | |
| ZA201108079B (en) | Composition and method for controlling pests | |
| PL2424530T3 (pl) | Sposób i kompozycja do leczenia cukrzycowej kwasicy ketonowej | |
| HK1145454A1 (en) | Pharmaceutical composition for preventing and treating diabetic nephropathy and preparation method thereof | |
| IL211904A0 (en) | Composition for treating disese | |
| HK1174825A1 (en) | Composition and method for skin repair | |
| EP2581086A4 (en) | COMPOSITION FOR PREVENTING OR TREATING OSTEOPOROSIS AND METHOD FOR MANUFACTURING THE SAME | |
| EP2512504A4 (en) | COMPOSITION AND THERAPEUTIC METHOD | |
| ZA201108151B (en) | Method and composition for treating macular degeneration | |
| EP2632432A4 (en) | COMPOSITION AND METHOD FOR TREATING LESIONS | |
| EP2393506A4 (en) | METHODS AND COMPOSITIONS FOR TREATING NEUROPATHIES | |
| GB0901667D0 (en) | Composition and method |